ZIF-8 with cationic defects toward efficient 125I2 uptake for in vitro radiotherapy of colon cancer

Xin Xin Tian, Yi Tong Liu, Yan Li, Xin Yu Qiu, Wen Hua Zhang, David J. Young, Qiu Chen

Research output: Contribution to journalArticlepeer-review

Abstract

Introducing 2,3-dimethyl-1H-imidazol-3-ium iodide (Dmim) as a monodentate ligand during the preparation of ZIF-8 yields ZIF-8 + (50) and ZIF-8 + (38) with cationic ‘missing linker’ defects. ZIF-8 + (38) adsorbs 125I2 and the resulting radioactive host-guest complex exhibits in vitro cytotoxicity comparable to that of Na125I against colon cancer cell line CT26.


Original languageEnglish
Pages (from-to)6942-6945
Number of pages4
JournalChemical Communications
Volume58
Issue number49
DOIs
Publication statusPublished - 23 May 2022

Fingerprint

Dive into the research topics of 'ZIF-8 with cationic defects toward efficient 125I2 uptake for in vitro radiotherapy of colon cancer'. Together they form a unique fingerprint.

Cite this